Genoil (GNOLF) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to -$12036.0.
- Genoil's Enterprise Value fell 1502.29% to -$12036.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12036.0, marking a year-over-year decrease of 1502.29%. This contributed to the annual value of -$12036.0 for FY2024, which is 13862.01% down from last year.
- According to the latest figures from Q3 2025, Genoil's Enterprise Value is -$12036.0, which was down 1502.29% from -$12036.0 recorded in Q2 2025.
- Over the past 5 years, Genoil's Enterprise Value peaked at -$0.03 during Q2 2022, and registered a low of -$35200.0 during Q3 2022.
- For the 5-year period, Genoil's Enterprise Value averaged around -$9149.6, with its median value being -$5055.0 (2021).
- In the last 5 years, Genoil's Enterprise Value surged by 9999.95% in 2022 and then plummeted by 1814900765.69% in 2023.
- Genoil's Enterprise Value (Quarter) stood at -$12.0 in 2021, then tumbled by 41933.33% to -$5044.0 in 2022, then tumbled by 107.45% to -$10464.0 in 2023, then dropped by 15.02% to -$12036.0 in 2024, then changed by 0.0% to -$12036.0 in 2025.
- Its Enterprise Value stands at -$12036.0 for Q3 2025, versus -$12036.0 for Q2 2025 and -$12036.0 for Q1 2025.